F David Horgen

6PUBLICATIONS
12CO-AUTHORS
Neurology and neuromuscular diseasesBiologically active moleculesCheminformatics and quantitative structure-activity relationshipsCharacterisation of biological macromoleculesMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 18, 2026
Natural product-derived TRPM7 channel inhibitors in neurological injury: Mechanisms, pharmacological potential and translational challenges.

|Jun 11, 2026
Pharmacophore Directed Retrosynthesis Applied to Waixenicin A: Synthesis and Bioactivity of Derivatives Bearing a Minimal Proposed Pharmacophore.

|Mar 27, 2024
Transient Receptor Potential Melastatin 7 (TRPM7) Ion Channel Inhibitors: Preliminary SAR and Conformational Studies of Xenicane Diterpenoids from the Hawaiian Soft Coral Sarcothelia edmondsoni.

Guangmin Yao, Matthew R Parris, W Cedric Kuo

|Jan 25, 2023
Piericones A and B as Potent Antithrombotics: Nanomolar Noncompetitive Protein Disulfide Isomerase Inhibitors with an Unexpected Chemical Architecture.

Guijuan Zheng, Keyu Lv, Hao Wang

|Feb 22, 2020
Isolation, Structure Determination, and Synthesis of Cyclic Tetraglutamic Acids from Box Jellyfish Species Alatina alata and Chironex yamaguchii.

Justin Reinicke, Ryuju Kitatani, Shadi Sedghi Masoud

|Oct 12, 2017
Scalaradial Is a Potent Inhibitor of Transient Receptor Potential Melastatin 2 (TRPM2) Ion Channels.

John G Starkus, Peter Poerzgen, Kristine Layugan

Pageof 1

Frequent Collaborators

2 joint publications

Kenneth G Hull

2 joint publications

Daniel Romo

2 joint publications

Zhong-Ping Feng

1 joint publications

Kazuo Nagasawa